Lumingkit, Petronila M.

HRN: 04-89-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2026
CEFTRIAXONE 1G (VIAL)
05/18/2026
05/25/2026
IV
2g
OD
CAPMR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: